Working… Menu
Trial record 1 of 1 for:    02683941
Previous Study | Return to List | Next Study

Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumors (SPINET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02683941
Recruitment Status : Completed
First Posted : February 17, 2016
Last Update Posted : March 2, 2021
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 28, 2020
Actual Study Completion Date : February 28, 2020
Certification/Extension First Submitted : February 26, 2021